Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial candida bloodstream infections

Clinical and Vaccine Immunology

Volumn 18, Issue 12, 2011, Pages 2113-2117

  Del Bono, Valerio ^a   Delfino, Emanuele ^a   Furfaro, Elisa ^a   Mikulska, Malgorzata ^a   Nicco, Elena ^a   Bruzzi, Paolo ^a   Mularoni, Alessandra ^b   Bassetti, Matteo ^c   Viscoli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b HOSPITAL DE CRUCES   (Spain)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; CANDIDEMIA; CARBOHYDRATE ANALYSIS; CLINICAL EVALUATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FUNGAL COLONIZATION; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ANTIGENS, FUNGAL; BETA-GLUCANS; CANDIDEMIA; CLINICAL LABORATORY TECHNIQUES; CROSS INFECTION; EARLY DIAGNOSIS; HUMANS; IMMUNOASSAY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 83455210282     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05408-11     Document Type: Article

References (29)

1. Anonymous. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adult. MMWR Recommend. Rep. 41(RR-17):1-19.
2. Avni, T., L. Leibovici, and M. Paul. 2011. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J. Clin. Microbiol. 49:665-670.
3. Bassetti, M., et al. 2009. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J. Antimicrob. Chemother. 64:625-629.
4. Bille, J. 2010. New nonculture-based methods for the diagnosis of invasive candidiasis. Curr. Opin. Crit. Care 16:460-464.
5. Damiani, C., S. Le Gal, D. Lejeune. 2011. Serum (1-3)-β-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii. J. Clin. Microbiol. 49:2000-2002.
6. Del Bono, V., et al. 2009. Clinical evaluation of a (1,3)-β-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Clin. Vaccine Immunol. 16:1524-1526.
7. De Pauw, B., et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycosis Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
8. Falagas, M. E., K. E. Apostolou, V. D. Pappas. 2006. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur. J. Clin. Microbiol. Infect. Dis. 25:419-425. (Pubitemid 44078593)
9. Fernandez, J., B. L. Erstad, W. Petty, and D. E. Nix. 2009. Time to positive culture and identification for Candida bloodstream infections. Diagn. Microbiol. Infect. Dis. 64:402-407.
10. Hope, W. W., T. J. Walsh, D. W. Denning. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5:609-622. (Pubitemid 41383906)
11. Horn, D. L., et al. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the Prospective Antifungal Therapy Alliance Registry. Clin. Infect. Dis. 48:1695-1703.
12. Karageorgopoulos, D. E., et al. 2011. β-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin. Infect. Dis. 52:750-770.
13. Koo, S., J. M. Bryar, J. H. Page, L. R. Baden, and F. M. Marty. 2009. Diagnostic performance of the (1→3)-beta-D-glucan assay for invasive fungal disease. Clin. Infect. Dis. 49:1650-1659.
14. León, C., et al. 2006. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit. Care Med. 34:730-737.
15. León, C., et al. 2009. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit. Care Med. 37:1624-1633.
16. Marchetti, O., et al. 2004. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin. Infect. Dis. 38:311-320. (Pubitemid 38200105)
17. Mikulska, M., et al. 2011. Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients. Clin. Vaccine Immunol. 18:518-519.
18. Morrell, M., V. J. Fraser, and M. H. Kollef. 2005. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49:3640-3645. (Pubitemid 41233011)
19. Obayashi, T., K. Negishi, T. Suzuki, and N. Funata. 2008. Reappraisal of the serum (133)-β-D-glucan assay for the diagnosis of invasive fungal infections- a study based on autopsy cases from 6 years. Clin. Infect. Dis. 46:1864-1870.
20. Odabasi, Z., et al. 2006. Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med. Mycol. 44:267-272. (Pubitemid 43771933)
21. Ostrosky-Zeichner, L., et al. 2005. Multicenter clinical evaluation of the (133)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41:654-659. (Pubitemid 41170353)
22. Ostrosky-Zeichner, L., et al. 2011. Early treatment of candidemia in adults: a review. Med. Mycol. 49:113-120.
23. Persat, F., et al. 2008. Contribution of the (133)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 46:1009-1013. (Pubitemid 351379994)
24. Segal, B. H. 2009. Aspergillosis. N. Engl. J. Med. 360:1870-1884.
25. Senn, L., et al. 2008. 1,3-β-D-Glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin. Infect. Dis. 46:878-885. (Pubitemid 351417190)
26. Viscoli, C., et al. 1999. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin. Infect. Dis. 28:1071-1079. (Pubitemid 29203541)
27. Watanabe, T., A. Yasuoka, J. Tanuma. 2009. Serum as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin. Infect. Dis. 49:1128-1131.
28. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317. (Pubitemid 39050477)
29. Zaoutis, T. E., et al. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41:1232-1239. (Pubitemid 41532664)